MedTrace Logo

MRI Results in Dupuytren's Contracture Before and After Injection With Xiaflex

NCT01450397 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 5

Last updated 2017-04-17

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effects of XIAFLEX on your finger through MRI.

Conditions

  • Dupuytren's Disease

Interventions

BIOLOGICAL

XIAFLEX

One Injection of 0.58 mg of Xiaflex into the affected area of the hand.

Sponsors & Collaborators

  • Auxilium Pharmaceuticals, Inc.

    collaborator INDUSTRY

  • Hospital for Special Surgery, New York

    lead OTHER

Principal Investigators

  • Scott W Wolfe, MD · Hospital for Special Surgery, New York

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-01-31
Completion
2012-02-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01450397 on ClinicalTrials.gov